The bile acid TUDCA reduces age-related hyperinsulinemia in mice

Author(s)

Zangerolamo, Lucas ; Carvalho, Marina ; Barssotti, Leticia ; Soares, Gabriela M. ; Marmentini, Carine ; Boschero, Antonio C. ; Barbosa, Helena Cristina L.

• Document type: Journal article
• Source: SCIENTIFIC REPORTS; v. 12, n. 1, p. 16-pg., 2022-12-23.

Abstract

Aging is associated with glucose metabolism disturbances, such as insulin resistance and hyperinsulinemia, which contribute to the increased prevalence of type 2 diabetes (T2D) and its complications in the elderly population. In this sense, some bile acids have emerged as new therapeutic targets to treat TD2, as well as associated metabolic disorders. The taurine conjugated bile acid, tauroursodeoxycholic acid (TUDCA) improves glucose homeostasis in T2D, obesity, and Alzheimer's disease mice model. However, its effects in aged mice have not been explored yet. Here, we evaluated the actions of TUDCA upon glucose-insulin homeostasis in aged C57BL/6 male mice (18-month-old) treated with 300 mg/kg of TUDCA or its vehicle. TUDCA attenuated hyperinsulinemia and improved glucose homeostasis in aged mice, by enhancing liver insulin-degrading enzyme (IDE) expression and insulin clearance. Furthermore, the improvement in glucose-insulin homeostasis in these mice was accompanied by a reduction in adiposity, associated with adipocyte hypertrophy, and lipids accumulation in the liver. TUDCA-treated aged mice also displayed increased energy expenditure and metabolic flexibility, as well as a better cognitive ability. Taken together, our data highlight TUDCA as an interesting target for the attenuation of age-related hyperinsulinemia and its deleterious effects on metabolism. (AU)

• FAPESP's process: 18/20213-2 - Role of TUDCA bile acid in the glycemic and energetic metabolism of mice with Alzheimer's and senile
• Grantee: Lucas Zangerolamo
• Support Opportunities: Scholarships in Brazil - Master